LU83270A1 - Solutions concentrees stables de cisplastine dans un solvant - Google Patents

Solutions concentrees stables de cisplastine dans un solvant Download PDF

Info

Publication number
LU83270A1
LU83270A1 LU83270A LU83270A LU83270A1 LU 83270 A1 LU83270 A1 LU 83270A1 LU 83270 A LU83270 A LU 83270A LU 83270 A LU83270 A LU 83270A LU 83270 A1 LU83270 A1 LU 83270A1
Authority
LU
Luxembourg
Prior art keywords
cisplatin
solution
approximately
polyethylene glycol
per
Prior art date
Application number
LU83270A
Other languages
English (en)
French (fr)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of LU83270A1 publication Critical patent/LU83270A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
LU83270A 1980-03-31 1981-03-31 Solutions concentrees stables de cisplastine dans un solvant LU83270A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13537380A 1980-03-31 1980-03-31
US13537380 1980-03-31

Publications (1)

Publication Number Publication Date
LU83270A1 true LU83270A1 (fr) 1981-10-29

Family

ID=22467813

Family Applications (1)

Application Number Title Priority Date Filing Date
LU83270A LU83270A1 (fr) 1980-03-31 1981-03-31 Solutions concentrees stables de cisplastine dans un solvant

Country Status (30)

Country Link
JP (1) JPS56152415A (it)
KR (1) KR860000841B1 (it)
AR (1) AR225500A1 (it)
AT (1) AT370996B (it)
AU (1) AU541056B2 (it)
BE (1) BE888209A (it)
CA (1) CA1162479A (it)
CH (1) CH647481A5 (it)
CS (1) CS246051B2 (it)
DD (1) DD157762A5 (it)
DE (1) DE3112272A1 (it)
DK (1) DK158564C (it)
ES (1) ES500869A0 (it)
FI (1) FI70670C (it)
FR (1) FR2480605A1 (it)
GB (1) GB2074028B (it)
GR (1) GR72769B (it)
HU (1) HU183379B (it)
IE (1) IE51070B1 (it)
IL (1) IL62517A (it)
IT (1) IT1170838B (it)
LU (1) LU83270A1 (it)
NL (1) NL8101531A (it)
NO (1) NO156675C (it)
NZ (1) NZ196519A (it)
PH (1) PH17152A (it)
PT (1) PT72774B (it)
SE (1) SE455045B (it)
SU (1) SU1056893A3 (it)
ZA (1) ZA812084B (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1153974B (it) * 1982-09-23 1987-01-21 Erba Farmitalia Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento
NL8303657A (nl) * 1983-10-24 1985-05-17 Pharmachemie Bv Voor injectie geschikte, stabiele, waterige, zoutzuur bevattende oplossing van cisplatine, alsmede werkwijze ter bereiding daarvan.
FI895340A0 (fi) * 1988-11-14 1989-11-09 Bristol Myers Squibb Co Hypertonisk cisplatin-loesning.
DE69725747T2 (de) * 1996-08-23 2004-07-29 Sequus Pharmaceuticals, Inc., Menlo Park Liposome enthaltend cisplatin
AUPQ641100A0 (en) 2000-03-23 2000-04-15 Australia Nuclear Science & Technology Organisation Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents
JP4445304B2 (ja) 2004-03-26 2010-04-07 オンキヨー株式会社 スイッチングアンプ
US8852566B2 (en) * 2009-03-26 2014-10-07 Warsaw Orthopedic, Inc. Compositions and methods for preferential distribution of active agents to injury sites
KR20200136997A (ko) 2018-03-29 2020-12-08 프로젝트 파마슈틱스 게엠베하 액체 약학적 제형

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177263A (en) * 1972-02-28 1979-12-04 Research Corporation Anti-animal tumor method
SE445172B (sv) * 1978-05-30 1986-06-09 Bristol Myers Co Stabil, steril vattenlosning av cisplatin i enhetsdoseringsform

Also Published As

Publication number Publication date
GB2074028A (en) 1981-10-28
BE888209A (fr) 1981-09-30
FR2480605B1 (it) 1984-05-11
DE3112272C2 (it) 1990-09-27
AR225500A1 (es) 1982-03-31
DK144281A (da) 1981-10-01
DD157762A5 (de) 1982-12-08
JPS6360008B2 (it) 1988-11-22
DK158564C (da) 1990-11-05
IE51070B1 (en) 1986-09-17
NZ196519A (en) 1983-06-17
IE810715L (en) 1981-09-30
IL62517A (en) 1984-01-31
SU1056893A3 (ru) 1983-11-23
CA1162479A (en) 1984-02-21
DK158564B (da) 1990-06-11
ES8206545A1 (es) 1982-08-16
IL62517A0 (en) 1981-05-20
AU6816681A (en) 1981-10-08
AT370996B (de) 1983-05-25
CH647481A5 (fr) 1985-01-31
HU183379B (en) 1984-04-28
PT72774B (en) 1982-11-16
DE3112272A1 (de) 1982-04-29
PT72774A (en) 1981-04-01
GB2074028B (en) 1983-09-21
SE455045B (sv) 1988-06-20
ZA812084B (en) 1982-04-28
NO156675C (no) 1987-11-04
JPS56152415A (en) 1981-11-26
FI810934L (fi) 1981-10-01
KR830004849A (ko) 1983-07-20
FR2480605A1 (fr) 1981-10-23
PH17152A (en) 1984-06-13
ATA150481A (de) 1982-10-15
IT8148090A0 (it) 1981-03-24
FI70670C (fi) 1986-10-06
CS246051B2 (en) 1986-10-16
FI70670B (fi) 1986-06-26
IT1170838B (it) 1987-06-03
NL8101531A (nl) 1981-10-16
AU541056B2 (en) 1984-12-13
KR860000841B1 (ko) 1986-07-09
NO156675B (no) 1987-07-27
GR72769B (it) 1983-12-02
SE8101990L (sv) 1981-11-13
ES500869A0 (es) 1982-08-16
NO811081L (no) 1981-10-01

Similar Documents

Publication Publication Date Title
US4451447A (en) Pharmaceutical formulations
US4322391A (en) Process for the preparation of microcrystalline cisplatin
EP1453517A1 (en) Platinum derivative pharmaceutical formulations
FR2571966A1 (fr) Compositions therapeutiques contenant des anthracyclines-glucosides.
FR2751875A1 (fr) Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
CN101248036A (zh) 邻乙酰基水杨酸与碱性氨基酸的盐和甘氨酸的稳定的活性物质络合物
WO2012094033A1 (en) Methods of making liposomes, liposome compositions made by the methods, and methods of using the same
LU83270A1 (fr) Solutions concentrees stables de cisplastine dans un solvant
KR20170084107A (ko) 레바프라잔 염산염 다형체 및 그의 제조 방법
WO2005070425A1 (fr) Composition pharmaceutique de vinflunine destinee a une administration parenterale, procede de preparation et utilisation
JP2001515874A (ja) モノヒドロキサム酸塩のバナジウム錯体及び当該錯体で構成される医薬品組成物
CN103764100A (zh) 有机溶剂中小肾上腺素能激动剂盐形式的制剂
NZ230127A (en) Cis-sulphato-trans-dichloro-1,1-bis(aminomethyl)cyclopentane-platinum-(iv) and pharmaceutical compositions
CA1089365A (en) Super-saturated isosorbide dinitrate solution process for its production and its use
US20060275331A1 (en) Pharmaceutical composition, method of manufacturing and therapeutic use thereof
US4946689A (en) Concentrated, stabilized cis-diamminedinitratoplatinum solutions for conversion to cisplatin
JPH09328425A (ja) アポトーシス調節剤
CN101129374A (zh) 长春氟宁药物组合物及其制备方法与应用
FI72302C (fi) Foerfarande foer framstaellning av stabilt mikrokristallint cisplatin.
CA2537610A1 (en) Pharmaceutical composition, method of manufacturing and therapeutic use thereof
LU83606A1 (fr) Compositions et procede pharmaceutiques
JPH05178716A (ja) アズレン誘導体
LU82672A1 (fr) Acides 2-amino-3-(alkylthiobenzoyl)-phenylacetiques et derives,et leur utilisation comme anti-inflammatoires,analgesiques,et inhibant l'agglomeration des plaquettes sanguines
WO2024100213A1 (fr) Nanoclusters de fer, leurs procédés d'obtention et leurs utilisations pour lutter contre les carences en fer
DK157484B (da) Fremgangsmaade til fremstilling af et cisplatin-praeparat